Abatacept Treatment May Slow Atherosclerosis Progression

Patients receiving abatacept experienced smaller increases in mean IMT, max IMT, and plaque score compared with the csDMARD cohorts.

Related Keywords

Toho ,Saga ,Japan ,Japanese , ,Arthritis Research Therapy ,Peuropean League Against Rheumatism ,Toho University School Of Medicine ,Arthritis Research ,Toho University School ,